Marc C. Hochberg, MD, MPH, MACP, MACR

• 1965-1969: Franklin & Marshall College - A.B., cum laude
• 1969-1973: The Johns Hopkins University School of Medicine, M.D.
• 1973-1974: Intern in Medicine, The Johns Hopkins Hospital, Baltimore, Maryland
• 1974-1975: Assistant Resident in Medicine, The Johns Hopkins Hospital, Baltimore, Maryland
• 1975-1977: Postdoctoral Fellow, Connective Tissue Division, Department of Medicine, The Johns Hopkins University School of Medicine and Hospital, Baltimore, Maryland
• 1977-1979: The Johns Hopkins University School of Hygiene and Public Health, M.P.H.

Marc C. Hochberg, MD, MPH, received his M.D. and M.P.H. from The Johns Hopkins University School of Medicine and School of Hygiene and Public Health, respectively. He completed residency training in internal medicine and fellowship training in rheumatology at The Johns Hopkins Hospital. He was a member of the faculty of The Johns Hopkins University School of Medicine from 1977 to 1991, after which he became Professor of Medicine and Epidemiology & Public Health and Head, Division of Rheumatology and Clinical Immunology at the University of Maryland School of Medicine. In 2014, he came Vice Chair, Department of Medicine at the University of Maryland School of Medicine as well as Director, Medical Care Clinical Center, Veteran Affairs Maryland Health Care System (VAMHCS). He retired from the full-time faculty at the University of Maryland School of Medicine and the VAMHCS in June 2024 and now holds the rank of Professor Emeritus, Departments of Medicine and Epidemiology and Public Health.

Dr. Hochberg received the Clinical Research Award from the Osteoarthritis Research Society International (OARSI) in 1999, was named one of only 50 “Postdoctoral Fellow Heroes” by the Arthritis Foundation in 2001, received the Mary Betty Stevens Clinical Research Award from the American College of Physicians (Maryland Chapter) in 2002, the Roger Demers Prize at the 42nd Laurentian Conference of Rheumatology in 2011, the Distinguished Clinical Investigator Award from the American College of Rheumatology (ACR) in 2012, the Lifetime Achievement Award from OARSI in 2013, the Arthur Modell Presidents Award from the Arthritis Foundation, Maryland Chapter in 2013 and the Distinguished Alumnus Award from both Franklin & Marshall College and The Johns Hopkins University in 2014. He was named a Master of both the American College of Physicians and the American College of Rheumatology in 2014. He was General Secretary and a member of the Board of Directors of OARSI, a member of the Board of Directors of both the ACR and the ACR Research and Education Foundation, President and a member of the Board of Directors of the U.S. Bone and Joint Initiative (USBJI) and Chair, Standing Committee on Epidemiology of the International League of Associations of Rheumatology.

He has published over 500 peer-reviewed articles and 60 book chapters, and is an editor of the textbooks “Rheumatology, 8th edition” (Mosby/Elsevier, 2023), “Epidemiology of the Rheumatic Diseases, 2nd edition” (Oxford University Press, 2001), and “Rheumatoid Arthritis” (Mosby/Elsevier, 2009). He is currently the Editor-in-Chief of Seminars in Arthritis and Rheumatism..

Dr. Hochberg’s research focused on the clinical epidemiology of musculoskeletal disorders, particularly osteoarthritis and osteoporosis. He was Principal Investigator (PI) of the Baltimore Clinical Center for the Osteoarthritis Initiative and the Study of Osteoporotic Fractures. He also was Co-PI of the Baltimore Hip Studies and Co-Director of the Pilot and Exploratory Studies Core of the University of Maryland Claude Pepper Older Americans Independence Center. His research was funded by the National Institutes of Health.

Câmara SMA, Hochberg MC, Miller R, Ryan AS, Orwig D, Gruber-Baldini AL, Guralnik J, Magder LS, Feng Z, Falvey JR, Beamer BA, Magaziner J: Sustained IL-6 and sTNF-aR1 levels after hip fracture predict 5-year mortality: a prospective cohort study from the Baltimore Hip Studies. J Am Geriatr Soc 2024 Jun 12. Online ahead of print. PMID: 38864591.

Alhassan E, Nguyen K, Hochberg MC, Mitchell BD: Causal factors for osteoarthritis: a scoping review of Mendelian randomization studies. Arthritis Care Res (Hoboken) 2024;76(3):366-75. PMID: 37846209.

Kim JS, Borges S, Clauw DJ, Conaghan PG, Felson DT, Fleming TR, Glaser R, Hart E, Hochberg M, Kim Y, Kraus VB, Lapteva L, Li X, Majumdar S, McAlindon TE, Mobasher A, Neogi T, Roemer FW, Rothwell R, Shibuya R, Siegel J, Simon LS, Spindler KP, Nikolov NP: FDA/Arthritis Foundation osteoarthritis drug development workshop recap: assessment of long-term benefit. Semin Arthritis Rheum 2022 Oct 56:152070. PMID: 35870222.

Hochberg MC, Carrino JA, Schnitzer TJ, Guermazi A, Walsh DA, White A, Nakajo S, Fountaine RJ, Hickman A, Pixton G, Viktrup L, Brown MT, West CR, Verburg KM: Long-term safety and efficacy of subcutaneous tanezumab versus nonsteroidal anti-inflammatory drugs for hip or knee osteoarthritis: a randomized trial. Arthritis Rheumatol. 2021;73(7):1167-77. PMID: 33538113

Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, Callahan L, Copenhaver C, Dodge C, Felson D, Gellar K, Harvey WF, Hawker G, Herzig E, Kwoh CK, Nelson AE, Samuels J, Scanzello C, White D, Wise B, Altman RD, DiRenzo D, Fontanarosa J, Giradi G, Ishimori M, Misra D, Shah AA, Shmagel AK, Thoma LM, Turgunbaev M, Turner AS, Reston J: 2019 American College of Rheumatology/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol 2020;72(2):220-33.

Hochberg MC, Guermazi A, Guehring H, Aydermir A, Wax S, Fleuranceau-Morel P, Bihlet AR, Byrjalsen I, Andersen JR, Eckstein F: Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: The FORWARD randomized clinical trial. JAMA 2019;322(14):1360-70.